{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T11:37:14Z","timestamp":1786621034469,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":224,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-06132-z","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T11:10:18Z","timestamp":1786619418000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["GPR84 and Neuroinflammation: A Receptor Worth Targeting, or A Target Worth Reconsidering?"],"prefix":"10.1007","volume":"63","author":[{"given":"Julia","family":"Jarco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Malek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"issue":"12","key":"6132_CR1","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nrd.2017.178","volume":"16","author":"AS Hauser","year":"2017","unstructured":"Hauser AS, Attwood MM, Rask-Andersen M, Schi\u00f6th HB, Gloriam DE (2017) Trends in GPCR drug discovery: new agents, targets and indications. Nat Rev Drug Discov 16(12):829\u2013842. https:\/\/doi.org\/10.1038\/nrd.2017.178","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"6132_CR2","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41573-025-01139-y","volume":"24","author":"JS Lorente","year":"2025","unstructured":"Lorente JS, Sokolov AV, Ferguson G, Schi\u00f6th HB, Hauser AS, Gloriam DE (2025) GPCR drug discovery: new agents, targets and indications. Nat Rev Drug Discov 24(6):458\u2013479. https:\/\/doi.org\/10.1038\/s41573-025-01139-y","journal-title":"Nat Rev Drug Discov"},{"key":"6132_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105087","author":"AS Schulze","year":"2022","unstructured":"Schulze AS, Kleinau G, Krakowsky R, Rochmann D, Das R, Worth CL, Krumbholz P, Scheerer P, et al. (2022) Evolutionary analyses reveal immune cell receptor GPR84 as a conserved receptor for bacteria-derived molecules. iScience. https:\/\/doi.org\/10.1016\/j.isci.2022.105087","journal-title":"iScience"},{"issue":"15","key":"6132_CR4","doi-asserted-by":"publisher","first-page":"10684","DOI":"10.1074\/jbc.M112.420042","volume":"288","author":"M Suzuki","year":"2013","unstructured":"Suzuki M, Takaishi S, Nagasaki M, Onozawa Y, Iino I, Maeda H, Komai T, Oda T (2013) Medium-chain fatty acid-sensing receptor, GPR84, is a proinflammatory receptor. J Biol Chem 288(15):10684\u201310691. https:\/\/doi.org\/10.1074\/jbc.M112.420042","journal-title":"J Biol Chem"},{"issue":"2","key":"6132_CR5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1124\/pr.118.016790","volume":"71","author":"T Kenakin","year":"2019","unstructured":"Kenakin T (2019) Biased receptor signalling in drug discovery. Pharmacol Rev 71(2):267\u2013315. https:\/\/doi.org\/10.1124\/pr.118.016790","journal-title":"Pharmacol Rev"},{"issue":"10","key":"6132_CR6","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1111\/bph.16098","volume":"181","author":"S Marsango","year":"2024","unstructured":"Marsango S, Milligan G (2024) Regulation of the pro-inflammatory G protein-coupled receptor GPR84. Br J Pharmacol 181(10):1500\u20131508. https:\/\/doi.org\/10.1111\/bph.16098","journal-title":"Br J Pharmacol"},{"issue":"23","key":"6132_CR7","doi-asserted-by":"publisher","first-page":"8959","DOI":"10.1523\/JNEUROSCI.3558-14.2015","volume":"35","author":"LSC Nicol","year":"2015","unstructured":"Nicol LSC, Dawes JM, Russa FL, Didangelos A, Clark AK, Gentry C, Grist J, Davies JB, et al. (2015) The role of G-protein receptor 84 in experimental neuropathic pain. J Neurosci 35(23):8959\u20138969. https:\/\/doi.org\/10.1523\/JNEUROSCI.3558-14.2015","journal-title":"J Neurosci"},{"issue":"3","key":"6132_CR8","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1006\/jmbi.2001.4520","volume":"307","author":"T Wittenberger","year":"2001","unstructured":"Wittenberger T, Schaller HC, Hellebrand S (2001) An expressed sequence tag (EST) data mining strategy succeeding in the discovery of new G-protein coupled receptors. J Mol Biol 307(3):799\u2013813. https:\/\/doi.org\/10.1006\/jmbi.2001.4520","journal-title":"J Mol Biol"},{"issue":"6","key":"6132_CR9","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1189\/jlb.69.6.1045","volume":"69","author":"S Yousefi","year":"2001","unstructured":"Yousefi S, Cooper PR, Potter SL, Mueck B, Jarai G (2001) Cloning and expression analysis of a novel G-protein-coupled receptor selectively expressed on granulocytes. J Leukoc Biol 69(6):1045\u20131052","journal-title":"J Leukoc Biol"},{"issue":"10","key":"6132_CR10","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1111\/bph.16206","volume":"181","author":"R Aktar","year":"2024","unstructured":"Aktar R, Rondinelli S, Peiris M (2024) GPR84 in physiology\u2014many functions in many tissues. Br J Pharmacol 181(10):1524\u20131535. https:\/\/doi.org\/10.1111\/bph.16206","journal-title":"Br J Pharmacol"},{"issue":"1","key":"6132_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38985-6","volume":"14","author":"H Liu","year":"2023","unstructured":"Liu H, Zhang Q, He X, Jiang M, Wang S, Yan X, Cheng X, Liu Y, et al. (2023) Structural insights into ligand recognition and activation of the medium-chain fatty acid-sensing receptor GPR84. Nat Commun 14(1):3271. https:\/\/doi.org\/10.1038\/s41467-023-38985-6","journal-title":"Nat Commun"},{"key":"6132_CR12","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.bbi.2015.01.010","volume":"46","author":"J Audoy-R\u00e9mus","year":"2015","unstructured":"Audoy-R\u00e9mus J, Bozoyan L, Dumas A, Filali M, Lecours C, Lacroix S, Rivest S, Tremblay M-E, et al. (2015) GPR84 deficiency reduces microgliosis, but accelerates dendritic degeneration and cognitive decline in a mouse model of Alzheimer\u2019s disease. Brain Behav Immun 46:112\u2013120. https:\/\/doi.org\/10.1016\/j.bbi.2015.01.010","journal-title":"Brain Behav Immun"},{"issue":"8","key":"6132_CR13","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1002\/glia.20506","volume":"55","author":"C Bouchard","year":"2007","unstructured":"Bouchard C, Pag\u00e9 J, B\u00e9dard A, Tremblay P, Valli\u00e8res L (2007) G protein-coupled receptor 84, a microglia-associated protein expressed in neuroinflammatory conditions. Glia 55(8):790\u2013800. https:\/\/doi.org\/10.1002\/glia.20506","journal-title":"Glia"},{"issue":"10","key":"6132_CR14","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1111\/bph.16066","volume":"181","author":"H Forsman","year":"2024","unstructured":"Forsman H, Dahlgren C, M\u00e5rtensson J, Bj\u00f6rkman L, Sundqvist M (2024) Function and regulation of GPR84 in human neutrophils. Br J Pharmacol 181(10):1536\u20131549. https:\/\/doi.org\/10.1111\/bph.16066","journal-title":"Br J Pharmacol"},{"issue":"2","key":"6132_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41423-021-00832-3","volume":"19","author":"A Herrero-Cervera","year":"2022","unstructured":"Herrero-Cervera A, Soehnlein O, Kenne E (2022) Neutrophils in chronic inflammatory diseases. Cell Mol Immunol 19(2):177\u2013191. https:\/\/doi.org\/10.1038\/s41423-021-00832-3","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"6132_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.70379","volume":"15","author":"K Jiang","year":"2025","unstructured":"Jiang K, Zou Y, Song Y, Zhou L, Zhang B, Zhou X, Zhang X (2025) G-protein-coupled receptor 84 aggravates early brain injury via microglial NLRP3-ASC inflammasome after subarachnoid hemorrhage. Brain Behav 15(4):e70379. https:\/\/doi.org\/10.1002\/brb3.70379","journal-title":"Brain Behav"},{"key":"6132_CR17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jbior.2015.10.005","volume":"60","author":"L Norton","year":"2016","unstructured":"Norton L, Lindsay Y, Deladeriere A, Chessa T, Guillou H, Suire S, Lucocq J, Walker S, et al. (2016) Localizing the lipid products of PI3K\u03b3 in neutrophils. Adv Biol Regul 60:36\u201345. https:\/\/doi.org\/10.1016\/j.jbior.2015.10.005","journal-title":"Adv Biol Regul"},{"key":"6132_CR18","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aaz4003","author":"NK Rynkiewicz","year":"2020","unstructured":"Rynkiewicz NK, Anderson KE, Suire S, Collins DM, Karanasios E, Vadas O, Williams R, Oxley D, et al. (2020) G\u03b2\u03b3 is a direct regulator of endogenous p101\/p110\u03b3 and p84\/p110\u03b3 PI3K\u03b3 complexes in mouse neutrophils. Sci Signal. https:\/\/doi.org\/10.1126\/scisignal.aaz4003","journal-title":"Sci Signal"},{"issue":"25","key":"6132_CR19","doi-asserted-by":"publisher","first-page":"17791","DOI":"10.1074\/jbc.M114.576827","volume":"289","author":"CR Surve","year":"2014","unstructured":"Surve CR, Lehmann D, Smrcka AV (2014) A chemical biology approach demonstrates G protein \u03b2\u03b3 subunits are sufficient to mediate directional neutrophil chemotaxis. J Biol Chem 289(25):17791\u201317801. https:\/\/doi.org\/10.1074\/jbc.M114.576827","journal-title":"J Biol Chem"},{"issue":"5","key":"6132_CR20","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1091\/mbc.E14-05-0982","volume":"26","author":"X Xu","year":"2015","unstructured":"Xu X, Gera N, Li H, Yun M, Zhang L, Wang Y, Wang QJ, Jin T (2015) GPCR-mediated PLC\u03b2\u03b3\/PKC\u03b2\/PKD signalling pathway regulates the cofilin phosphatase slingshot 2 in neutrophil chemotaxis. Mol Biol Cell 26(5):874\u2013886. https:\/\/doi.org\/10.1091\/mbc.E14-05-0982","journal-title":"Mol Biol Cell"},{"issue":"2","key":"6132_CR21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1124\/jpet.116.232033","volume":"357","author":"Q Zhang","year":"2016","unstructured":"Zhang Q, Yang H, Li J, Xie X (2016) Discovery and characterization of a novel small-molecule agonist for medium-chain free fatty acid receptor G protein-coupled receptor 84. J Pharmacol Exp Ther 357(2):337\u2013344. https:\/\/doi.org\/10.1124\/jpet.116.232033","journal-title":"J Pharmacol Exp Ther"},{"key":"6132_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01419","author":"C Recio","year":"2018","unstructured":"Recio C, Lucy D, Purvis GSD, Iveson P, Zeboudj L, Iqbal AJ, Lin D, O\u2019Callaghan C, et al. (2018) Activation of the immune-metabolic receptor GPR84 enhances inflammation and phagocytosis in macrophages. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2018.01419","journal-title":"Front Immunol"},{"issue":"8","key":"6132_CR23","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1038\/s41401-021-00825-y","volume":"43","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Chen L, Yang H, Fang Y, Wang S, Wang M, Yuan Q, Wu W, et al. (2022) GPR84 signalling promotes intestinal mucosal inflammation via enhancing NLRP3 inflammasome activation in macrophages. Acta Pharmacol Sin 43(8):2042\u20132054. https:\/\/doi.org\/10.1038\/s41401-021-00825-y","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"6132_CR24","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1159\/000514887","volume":"13","author":"J M\u00e5rtensson","year":"2021","unstructured":"M\u00e5rtensson J, Sundqvist M, Manandhar A, Ieremias L, Zhang L, Ulven T, Xie X, Bj\u00f6rkman L, et al. (2021) The two formyl peptide receptors differently regulate GPR84-mediated neutrophil NADPH oxidase activity. J Innate Immun 13(4):242\u2013256. https:\/\/doi.org\/10.1159\/000514887","journal-title":"J Innate Immun"},{"issue":"1","key":"6132_CR25","doi-asserted-by":"publisher","first-page":"389","DOI":"10.18632\/aging.202144","volume":"13","author":"W-S Gao","year":"2020","unstructured":"Gao W-S, Qu Y-J, Huai J, Wei H, Zhang Y, Yue S-W (2020) DOK3 is involved in microglial cell activation in neuropathic pain by interacting with GPR84. Aging (Albany NY) 13(1):389\u2013410. https:\/\/doi.org\/10.18632\/aging.202144","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"6132_CR26","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1021\/acs.jmedchem.3c00951","volume":"67","author":"P Wang","year":"2024","unstructured":"Wang P, Raja A, Luscombe VB, Bataille CJR, Lucy D, Rogga VV, Greaves DR, Russell AJ (2024) Development of highly potent, G-protein pathway biased, selective, and orally bioavailable GPR84 agonists. J Med Chem 67(1):110\u2013137. https:\/\/doi.org\/10.1021\/acs.jmedchem.3c00951","journal-title":"J Med Chem"},{"key":"6132_CR27","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41586-026-10191-6","volume":"652","author":"TO Cox","year":"2026","unstructured":"Cox TO, Devason AS, de Araujo A et al (2026) Intestinal interoceptive dysfunction drives age-associated cognitive decline. Nature 652:442\u2013450. https:\/\/doi.org\/10.1038\/s41586-026-10191-6","journal-title":"Nature"},{"issue":"5","key":"6132_CR28","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1021\/acsptsci.1c00151","volume":"4","author":"L Jenkins","year":"2021","unstructured":"Jenkins L, Marsango S, Mancini S, Mahmud ZA, Morrison A, McElroy SP, Bennett KA, Barnes M, et al. (2021) Discovery and characterization of novel antagonists of the proinflammatory orphan receptor GPR84. ACS Pharmacol Transl Sci 4(5):1598\u20131613. https:\/\/doi.org\/10.1021\/acsptsci.1c00151","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"9","key":"6132_CR29","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1021\/acschembio.9b00533","volume":"14","author":"D Lucy","year":"2019","unstructured":"Lucy D, Purvis GSD, Zeboudj L, Chatzopoulou M, Recio C, Bataille CJR, Wynne GM, Greaves DR, et al. (2019) A biased agonist at immunometabolic receptor GPR84 causes distinct functional effects in macrophages. ACS Chem Biol 14(9):2055\u20132064. https:\/\/doi.org\/10.1021\/acschembio.9b00533","journal-title":"ACS Chem Biol"},{"issue":"9","key":"6132_CR30","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1002\/cpdd.955","volume":"10","author":"H Timmis","year":"2021","unstructured":"Timmis H, Van Kaem T, Desrivot J, Dupont S, Meuleners L, Beetens J, Helmer E, Santermans E, et al. (2021) GLPG1205, a GPR84 modulator: safety, pharmacokinetics, and pharmacodynamics in healthy subjects. Clin Pharmacol Drug Dev 10(9):994\u20131006. https:\/\/doi.org\/10.1002\/cpdd.955","journal-title":"Clin Pharmacol Drug Dev"},{"key":"6132_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26020490","author":"M Schwarzfischer","year":"2025","unstructured":"Schwarzfischer M, Walker MR, Curcio M, Boshta NM, Marchand A, Soons E, P\u00f6hlmann D, Wawrzyniak M, et al. (2025) Synthetic GPR84 agonists in colorectal cancer: effective in THP-1 cells but ineffective in BMDMs and MC38 mouse tumor models. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26020490","journal-title":"Int J Mol Sci"},{"issue":"5","key":"6132_CR32","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1165\/rcmb.2023-0221LE","volume":"70","author":"C Donovan","year":"2024","unstructured":"Donovan C, Thorpe AE, Gomez HM, Carroll OR, Feng M, Bai X, Chen H, Horvat JC, et al. (2024) The GPR84 antagonist GLPG1205 reduces features of disease in experimental severe asthma. Am J Respir Cell Mol Biol 70(5):424\u2013427. https:\/\/doi.org\/10.1165\/rcmb.2023-0221LE","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"6132_CR33","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01794-2022","volume":"61","author":"IR Strambu","year":"2023","unstructured":"Strambu IR, Seemayer CA, Fagard LM-CA, Ford PA, Van der Aa TAK, de Haas-Amatsaleh AA, Modgill V, Santermans E, et al. (2023) GLPG1205 for idiopathic pulmonary fibrosis: a phase 2 randomised placebo-controlled trial. Eur Respir J 61(3):2201794. https:\/\/doi.org\/10.1183\/13993003.01794-2022","journal-title":"Eur Respir J"},{"issue":"8","key":"6132_CR34","doi-asserted-by":"publisher","first-page":"7973","DOI":"10.1021\/acs.jmedchem.4c02335","volume":"68","author":"L Ieremias","year":"2025","unstructured":"Ieremias L, Manandhar A, Schultz-Knudsen K, Kaspersen MH, Vrettou CI, Rexen Ulven E, Ulven T (2025) Minimal structural variation of GPR84 full agonist causes functional switch to inverse agonism. J Med Chem 68(8):7973\u20138009. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c02335","journal-title":"J Med Chem"},{"issue":"7","key":"6132_CR35","doi-asserted-by":"publisher","first-page":"7945","DOI":"10.1021\/acs.jmedchem.5c03367","volume":"69","author":"MA Malone","year":"2026","unstructured":"Malone MA, Yin R, Li Y, Jenkins L, Guseinov AA, Marsango S, Huggett M, Huggett M, et al. (2026) Discovery, structure-activity relationship, and functional characterization of a chromenopyrrole series as orthosteric antagonists of GPR84. J Med Chem 69(7):7945\u20137965. https:\/\/doi.org\/10.1021\/acs.jmedchem.5c03367","journal-title":"J Med Chem"},{"issue":"5","key":"6132_CR36","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.4049\/jimmunol.1400401","volume":"193","author":"B Aub\u00e9","year":"2014","unstructured":"Aub\u00e9 B, L\u00e9vesque SA, Par\u00e9 A, Chamma \u00c9, K\u00e9bir H, Gorina R, L\u00e9cuyer M-A, Alvarez JI, et al. (2014) Neutrophils mediate blood\u2013spinal cord barrier disruption in demyelinating neuroinflammatory diseases. J Immunol 193(5):2438\u20132454. https:\/\/doi.org\/10.4049\/jimmunol.1400401","journal-title":"J Immunol"},{"issue":"4","key":"6132_CR37","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nri.2017.10","volume":"17","author":"O Soehnlein","year":"2017","unstructured":"Soehnlein O, Steffens S, Hidalgo A, Weber C (2017) Neutrophils as protagonists and targets in chronic inflammation. Nat Rev Immunol 17(4):248\u2013261. https:\/\/doi.org\/10.1038\/nri.2017.10","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"6132_CR38","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1523\/JNEUROSCI.2405-14.2015","volume":"35","author":"JM Morganti","year":"2015","unstructured":"Morganti JM, Jopson TD, Liu S, Riparip L-K, Guandique CK, Gupta N, Ferguson AR, Rosi S (2015) CCR2 antagonism alters brain macrophage polarization and ameliorates cognitive dysfunction induced by traumatic brain injury. J Neurosci 35(2):748\u2013760. https:\/\/doi.org\/10.1523\/JNEUROSCI.2405-14.2015","journal-title":"J Neurosci"},{"issue":"2","key":"6132_CR39","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.imlet.2005.05.010","volume":"101","author":"C Venkataraman","year":"2005","unstructured":"Venkataraman C, Kuo F (2005) The G-protein coupled receptor, GPR84 regulates IL-4 production by T lymphocytes in response to CD3 crosslinking. Immunol Lett 101(2):144\u2013153. https:\/\/doi.org\/10.1016\/j.imlet.2005.05.010","journal-title":"Immunol Lett"},{"issue":"45","key":"6132_CR40","doi-asserted-by":"publisher","first-page":"34457","DOI":"10.1074\/jbc.M608019200","volume":"281","author":"J Wang","year":"2006","unstructured":"Wang J, Wu X, Simonavicius N, Tian H, Ling L (2006) Medium-chain fatty acids as ligands for orphan G protein-coupled receptor GPR84. J Biol Chem 281(45):34457\u201334464. https:\/\/doi.org\/10.1074\/jbc.M608019200","journal-title":"J Biol Chem"},{"issue":"1","key":"6132_CR41","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12974-017-0970-y","volume":"14","author":"L Wei","year":"2017","unstructured":"Wei L, Tokizane K, Konishi H, Yu H-R, Kiyama H (2017) Agonists for G-protein-coupled receptor 84 (GPR84) alter cellular morphology and motility but do not induce pro-inflammatory responses in microglia. J Neuroinflammation 14(1):198. https:\/\/doi.org\/10.1186\/s12974-017-0970-y","journal-title":"J Neuroinflammation"},{"issue":"1","key":"6132_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-020-00221-2","volume":"9","author":"HS Kwon","year":"2020","unstructured":"Kwon HS, Koh S-H (2020) Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Transl Neurodegener 9(1):42. https:\/\/doi.org\/10.1186\/s40035-020-00221-2","journal-title":"Transl Neurodegener"},{"issue":"1","key":"6132_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-18159-3","volume":"7","author":"ZA Mahmud","year":"2017","unstructured":"Mahmud ZA, Jenkins L, Ulven T, Lab\u00e9gu\u00e8re F, Gosmini R, De Vos S, Hudson BD, Tikhonova IG, et al. (2017) Three classes of ligands each bind to distinct sites on the orphan G protein-coupled receptor GPR84. Sci Rep 7(1):17953. https:\/\/doi.org\/10.1038\/s41598-017-18159-3","journal-title":"Sci Rep"},{"issue":"7","key":"6132_CR44","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1093\/brain\/awx113","volume":"140","author":"T Zrzavy","year":"2017","unstructured":"Zrzavy T, Hametner S, Wimmer I, Butovsky O, Weiner HL, Lassmann H (2017) Loss of \u2018homeostatic\u2019 microglia and patterns of their activation in active multiple sclerosis. Brain 140(7):1900\u20131913. https:\/\/doi.org\/10.1093\/brain\/awx113","journal-title":"Brain"},{"issue":"1","key":"6132_CR45","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.expneurol.2012.06.011","volume":"237","author":"B Liao","year":"2012","unstructured":"Liao B, Zhao W, Beers DR, Henkel JS, Appel SH (2012) Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS. Exp Neurol 237(1):147\u2013152. https:\/\/doi.org\/10.1016\/j.expneurol.2012.06.011","journal-title":"Exp Neurol"},{"issue":"1","key":"6132_CR46","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neuron.2006.09.021","volume":"52","author":"JN Campbell","year":"2006","unstructured":"Campbell JN, Meyer RA (2006) Mechanisms of neuropathic pain. Neuron 52(1):77\u201392. https:\/\/doi.org\/10.1016\/j.neuron.2006.09.021","journal-title":"Neuron"},{"key":"6132_CR47","doi-asserted-by":"publisher","unstructured":"Gagnon L, Leduc M, Thibodeau J-F, Zhang M-Z, Grouix B, Sarra-Bournet F, Gagnon W, Hince K. Tremblay M, Geerts L, Kennedy CRJ, H\u00e9bert RL, Gutsol A, Holterman CE, Kamto E, Gervais L, Ouboudinar J, Richard J, Felton A, \u2026 Laurin P (2018) A newly discovered antifibrotic pathway regulated by two fatty acid receptors: GPR40 and GPR84. Am J Pathol 188(5):1132\u20131148. https:\/\/doi.org\/10.1016\/j.ajpath.2018.01.009","DOI":"10.1016\/j.ajpath.2018.01.009"},{"issue":"3","key":"6132_CR48","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-023-03603-3","volume":"73","author":"J Li","year":"2024","unstructured":"Li J, Ma A, Zhang R, Chen Y, Bolyard C, Zhao B, Wang C, Pich T, et al. (2024) Targeting metabolic sensing switch GPR84 on macrophages for cancer immunotherapy. Cancer Immunol Immunother 73(3):52. https:\/\/doi.org\/10.1007\/s00262-023-03603-3","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"6132_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-38539-1","volume":"9","author":"SJ Mancini","year":"2019","unstructured":"Mancini SJ, Mahmud ZA, Jenkins L, Bolognini D, Newman R, Barnes M, Edye ME, McMahon SB, et al. (2019) On-target and off-target effects of novel orthosteric and allosteric activators of GPR84. Sci Rep 9(1):1861. https:\/\/doi.org\/10.1038\/s41598-019-38539-1","journal-title":"Sci Rep"},{"issue":"21","key":"6132_CR50","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2536372123","volume":"123","author":"M Kalita","year":"2026","unstructured":"Kalita M, Kuo RC, Straniero V, Reyes ST, Pandrala M, Lanzini A, Marsango S, D\u2019Moore D, et al. (2026) Illuminating proinflammatory myeloid cells with PET tracers targeting GPR84. Proc Natl Acad Sci USA 123(21):e2536372123. https:\/\/doi.org\/10.1073\/pnas.2536372123","journal-title":"Proc Natl Acad Sci USA"},{"key":"6132_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175960","volume":"956","author":"VB Luscombe","year":"2023","unstructured":"Luscombe VB, Baena-L\u00f3pez LA, Bataille CJR, Russell AJ, Greaves DR (2023) Kinetic insights into agonist-dependent signalling bias at the pro-inflammatory G-protein coupled receptor GPR84. Eur J Pharmacol 956:175960. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175960","journal-title":"Eur J Pharmacol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06132-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06132-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06132-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T11:10:19Z","timestamp":1786619419000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-06132-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6132"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06132-z","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable (review article).","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work the author(s) used\u00a0\n                      ChatGPT (OpenAI)\n                      \u00a0to support\u00a0language grammar and editing. After using this tool, the author(s) carefully reviewed, verified, and edited the content to ensure accuracy and originality, and take(s) full responsibility for the published article. Figures and graphical abstract were prepared with the use of\n                      BioRender\n                      tool.","order":2,"name":"Ethics","label":"Declaration of generative AI and AI-assisted technologies in the manuscript preparation process","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"831"}}